← Back to Patent Explorer
US4382086A Expired / Lapsed US ⏱️ 0.0 years remaining

9-Dihydro-11,12-ketal derivatives of erythromycin A and epi-erythromycin A

Assignee: Pfizer Inc
•
Filing: 1982-03-01
•
Granted: 1983-05-03
•
Expires: 2002-03-01
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Antibacterial macrolides derived from 9-dihydro-11,12-O-isopropylidene-erythromycin A and 9-dihydro-11,12-O-isopropylidene-4''-epi-erythromycin A.

Inventors

  • 👤 Frank C. Sciavolino
  • 👤 James R. Hauske

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-07 10:51
CPC Classifications
C; C07; C07H; C07H17/00; C07H17/04; C07H17/08; A; A61; A61P; A61P31/00; A61P31/04

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 42 words
A compound selected from the group consisting of a macrolide of the formula: ##STR5## and the pharmaceutically acceptable acid addition salts thereof, wherein R is selected from the group consisting of hydrogen, alkanoyl having two to three carbon atoms and ethyl succinyl.
Claim 2
Dependent Claim 42 words
A compound selected from the group consisting of a macrolide of the formula: ##STR5## and the pharmaceutically acceptable acid addition salts thereof, wherein R is selected from the group consisting of hydrogen, alkanoyl having two to three carbon atoms and ethyl succinyl.
Claim 3
Dependent Claim 9 words
A compound of claim 1, wherein R is hydrogen.
Claim 4
Dependent Claim 13 words
The compound of claim 2, wherein the C 4" -hydroxyl group is axial.
Claim 5
Dependent Claim 13 words
The compound of claim 2, wherein the C 4" -hydroxyl group is equatorial.
Claim 6
Dependent Claim 30 words
An antibacterial pharmaceutical composition comprising from about 0.5 to about 90 percent by weight of the total composition a compound as claimed in claim 1 and a pharmaceutically acceptable carrier.

References Cited (Backward Citations)

US2653899A Cited
US3417077A Cited
US3884903A Cited
US4150220A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1986-05-02 1986-11-01 1987-05-03 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1990-05-02 1990-11-01 1991-05-03 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1994-05-02 1994-11-01 1995-05-03 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag